Keros Therapeutics, Inc. (KROS)
NASDAQ: KROS · IEX Real-Time Price · USD
52.28
-1.71 (-3.17%)
May 17, 2024, 4:00 PM EDT - Market closed
Keros Therapeutics Employees
Keros Therapeutics had 136 employees on December 31, 2023. The number of employees increased by 31 or 29.52% compared to the previous year.
Employees
136
Change (1Y)
31
Growth (1Y)
29.52%
Revenue / Employee
$1,721
Profits / Employee
-$1,178,691
Market Cap
1.88B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 136 | 31 | 29.52% |
Dec 31, 2022 | 105 | 45 | 75.00% |
Dec 31, 2021 | 60 | 25 | 71.43% |
Dec 31, 2020 | 35 | 12 | 52.17% |
Dec 31, 2019 | 23 | - | - |
Sources: Annual number of employees according to filings submitted to the U.S. Securities and Exchange Commission (SEC). Data is also manually gathered from company press releases, IPO filings, and other official sources.
Related Stocks
Company Name | Employees |
---|---|
BrightSpring Health Services | 35,000 |
Warby Parker | 3,491 |
UFP Technologies | 3,093 |
NeoGenomics | 2,100 |
Galapagos NV | 1,123 |
Beam Therapeutics | 507 |
Agios Pharmaceuticals | 386 |
Syndax Pharmaceuticals | 184 |
KROS News
- 4 days ago - Keros Therapeutics to Present at the 29th Annual Congress of the European Hematology Association - GlobeNewsWire
- 10 days ago - Keros Therapeutics Reports Recent Business Highlights and First Quarter 2024 Financial Results - GlobeNewsWire
- 2 months ago - Keros Therapeutics to Present at Leerink Partners 2024 Global Biopharma Conference - GlobeNewsWire
- 2 months ago - Keros Therapeutics Reports Recent Business Highlights and Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Keros Therapeutics To Present at Pulmonary Vascular Research Institute 2024 Annual Congress - GlobeNewsWire
- 4 months ago - Keros Therapeutics Announces Closing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Keros Therapeutics Announces Pricing of Upsized Public Offering of Common Stock - GlobeNewsWire
- 4 months ago - Keros Therapeutics Announces Proposed Public Offering of Common Stock - GlobeNewsWire